Stay updated on Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial

Sign up to get notified when there's something new on the Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T15:46:16.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed, and the previous maintenance notice (Revision: v3.4.1) was removed.
    Difference
    0.4%
    Check dated 2026-02-11T04:55:20.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added, and the page now shows Revision: v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T05:36:46.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The changes are cosmetic/UI and metadata updates: the glossary toggle is shown, the capitalization of 'Met QC Criteria' is adjusted, the No FEAR Act data label is updated, and the revision/version is updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:07:48.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T02:26:52.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    A new Locations section was added listing study sites in Minnesota, New Jersey, New York, Pennsylvania, and Utah, and state-specific location subsections were removed. The page revision updated to v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-23T21:36:17.000Z thumbnail image

Stay in the know with updates to Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Emapalumab & Anakinra for COVID-19 Hyperinflammation Clinical Trial page.